Navigation Links
Curing addiction with cannabis medicines
Date:3/7/2008

Smokers trying to quit in the future could do it with the help of cannabis based medicines, according to research from The University of Nottingham.

Teams of pharmacologists, studying the cannabis-like compounds which exist naturally in our bodies (endocannabinoids), are exploring the potential for medical treatment. This includes treating conditions as diverse as obesity, diabetes, depression and addiction to substances like nicotine.

Scientists have known about endocannabinoids since the mid-1990s. This led to an explosion in the number of researchers looking into the future medical uses of cannabinoids and cannabis compounds.

Dr Steve Alexander, Associate Professor in the School of Biomedical Sciences, focused on a number of these projects in editing the first themed podcast for the British Journal of Pharmacology.

Dr Alexander said: It is clear that there is very realistic potential for cannabinoids as medicines. Scientists are looking at a range of possible applications.

One of these researchers is Professor David Kendall, a cellular pharmacologist at the University: The brain is full of cannabinoid receptors. And so, not surprisingly with diseases like depression and anxiety, theres a great deal of interest in exploiting these receptors and in doing so, developing anti-depressant compounds.

Addiction is a real target researchers like Professor Kendall believe the endocannabinoids could be a crucial link to addictive behaviour: We know that the endocannabinoid system is intimately involved in reward pathways and drug seeking behaviour. So this tends to indicate that that if the link involving endocannabinoids and the reward pathway, using inhibitors, can be interrupted, it could turn down the drive to seek addictive agents like nicotine.

Because cannabinoids have also been shown to bring down blood pressure, it is hoped that related compounds can be used in patients with conditions like hypertension.

Dr Michael Randall, a cardiovascular pharmacologist at the University has looked at how endocannabinoids cause blood vessels to relax. This could have many implications, Dr Randall said. The endocannabinoids appear to lower blood pressure under certain conditions; states of shock for example. If the endocannabinoids are of physiological importance, this could have real therapeutic possibilities.

In terms of getting better medicines the endocannabinoid system has a lot to offer, said Dr Alexander. The range of cannabis-related medicines is currently limited, but by increasing our knowledge in this area we can increase our stock.


'/>"/>

Contact: Dr. Steven Alexander
steve.alexander@nottingham.ac.uk
University of Nottingham
Source:Eurekalert

Related medicine news :

1. Business Leaders, Policy Makers and Advocates Gather to Discuss Strategies for Securing the Nations Economy by Investing in Early Childhood
2. Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams
3. Greenway Experiences Quick Success in the Community EHR Marketplace by Securing Contracts with 10 Community-Based Health Organizations
4. Lessons Learned in Securing Top Talent During University Recruiting
5. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
6. NEWSWEEK Cover: The Hunt for an Addiction Vaccine
7. Aussie neuroscientist tests addiction drug
8. UTMB wins $3.4 million federal grant to study addiction-recovery drugs
9. ARMSRx Tackles the New Rx Addiction -- Pharmacy Benefit Audits
10. DNA (driver of nicotine addiction)
11. Cleveland Addiction Agency and National Association Partner to Help Clergy Counsel the Children of Alcoholics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2016)... ... 13, 2016 , ... Valentine’s Day is nearly upon us, and most singles ... great outfit, flawless hair, and a sparkling personality are all well and good, but ... night at home with Rover. (Actually, man’s best friend might not even want to ...
(Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy lifestyle ... reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those giving ... high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV are ... The increasingly modern world of instantaneous consumption proves very convenient for businesses. With new ... oil and coal, which pollutes our air, water, and soil. It can also threaten ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, Inc. presented ... a VeinViewer® Vision vein finder for the nursing school simulation lab. ... and draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary goal ... future adoption patterns on the usage of liquid biopsy. ... following: - Timeframe of liquid biopsy adoption ... cfDNA and Evs—by organization type - Sample inflow to ... blood, saliva, stool, serum, and so on. - Correlation ...
Breaking Medicine Technology: